Prices delayed by at least 15 minutes | Print
Trellus Health PLC (TRLS)
ORD GBP0.0006Open
1.9p
Previous close
1.9p
Trade high
1.94p
Volume
539,815
Year high
9.65p
Year low
1.50p
Dividend yield
-
Market capitalisation
£3.13 mn
P/E ratio
2.61
ISIN
GB00BNNFM402
This share can be held in a Dealing accountISALifetime ISAJISASIPPand can be used with Dividend reinvestment
Share price
Company profile
Trellus Health PLC is commercializing the provision of digital chronic condition management solutions for employers and health plans that utilize the scientifically validated GRITT resilience-based methodology and a proprietary HIPAA-compliant technology platform called TrellusElevate to coordinate and deliver personalized care remotely via telehealth. The company is initially focused on Inflammatory Bowel Diseases, which include the chronic incurable conditions of Crohn's Disease and ulcerative colitis but considers its approach to have potential utility and demand across many chronic conditions.
News
Recent trades
| Date | Time | Price | Quantity | Value (£) |
|---|---|---|---|---|
| 03/05/2024 | 04:35:11 | 1.94 | 43,847 | 850.63 |
| 03/05/2024 | 04:19:24 | 1.62 | 72,500 | 1,174.50 |
| 03/05/2024 | 04:06:20 | 1.6 | 150,000 | 2,400.00 |
| 03/05/2024 | 02:44:18 | 1.62 | 618 | 10.01 |
| 03/05/2024 | 01:35:03 | 1.62 | 1,443 | 23.38 |
AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2024 AJ Bell. All rights reserved.